Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 36Thoracic 15Breast 15Head & Neck 13CNS 11Genitourinary 10Gynecologic 8Sarcoma 7Dermatologic 3Tumor-Agnostic 2Other neoplasm 2Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1Endocrine 1

Conditions

Stomatitis 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Radiotherapy 5Surveys and Questionnaires 4Cisplatin 4angiotensin I (1-7) 3alvimopan 3Radiation 3Injections 3Water 2Vitamin D 2Tirzepatide 2RRx-001 2Mouthwashes 2Metformin 2Interleukin 1 Receptor Antagonist Protein 2High-Intensity Focused Ultrasound Ablation 2Drug Therapy 2Dexmedetomidine 2Dexamethasone 2Calcium Dobesilate 2Amifostine 2Acetylcysteine 2tempol 1peppermint oil 1pegfilgrastim 1naloxegol 1methylnaltrexone 1methyl N-acetylsibirosaminide 1linaclotide 1licogliflozin 1kang-lai-te 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Celecoxib × Other × Clear all
NCT00698204 2014-06-05

Cox-2 Inhibition in Radiation-induced Oral Mucositis

UConn Health

Phase 2 Completed
43 enrolled 10 charts
Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡